Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309944 · ClinicalTrials.gov registry record · NA
Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
A NA study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT02309944 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 93 participants.
The verdict
NCT02309944, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of the study is to test whether the use of a new wound closure technique can decrease the rates of wound complications in obese cancer patients.
Interventions
- DEVICE Prevena™ Incision Management System
- PROCEDURE Standard Wound Closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2015-05 |
| Est. Completion | 2020-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02309944
The ClinicalTrials.gov registry entry for NCT02309944 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevena™ Incision Management System is the first listed.
NCT02309944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02309944 about?
NCT02309944 is a clinical study titled "Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients". The purpose of the study is to test whether the use of a new wound closure technique can decrease the rates of wound complications in obese cancer patients.
What is the current status of trial NCT02309944?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2015-05. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02309944?
The interventions under investigation include: Prevena™ Incision Management System (DEVICE), Standard Wound Closure (PROCEDURE).
Who is sponsoring clinical trial NCT02309944?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.